tiprankstipranks
Advertisement
Advertisement

DSKYF Stock Latest News

New Ovarian Cancer Maintenance Trial Puts Daiichi Sankyo’s R-DXd in the Late-Stage Spotlight
Company AnnouncementsNew Ovarian Cancer Maintenance Trial Puts Daiichi Sankyo’s R-DXd in the Late-Stage Spotlight
4d ago
DSKYF
Daiichi Sankyo Revises FY2025 Results and 5-Year Plan Materials
PremiumCompany Announcements
Daiichi Sankyo Revises FY2025 Results and 5-Year Plan Materials
18d ago
Daiichi Sankyo Issues Further Corrections to FY2025 Financial Reference Data
PremiumCompany Announcements
Daiichi Sankyo Issues Further Corrections to FY2025 Financial Reference Data
18d ago
Daiichi Sankyo Expands Lung Cancer Pipeline With New DS-3939a Trial
PremiumCompany Announcements
Daiichi Sankyo Expands Lung Cancer Pipeline With New DS-3939a Trial
24d ago
DSKYF
Daiichi Sankyo Flags Risks Around FY2026 Q1 Outlook and Pipeline Data
PremiumCompany Announcements
Daiichi Sankyo Flags Risks Around FY2026 Q1 Outlook and Pipeline Data
25d ago
Daiichi Sankyo Publishes Q1 FY2026 Consolidated Financial Reference Data
PremiumCompany AnnouncementsDaiichi Sankyo Publishes Q1 FY2026 Consolidated Financial Reference Data
25d ago
Daiichi Sankyo Posts Strong Q1 Revenue Growth but Lower Net Profit, Lifts Dividend Outlook
Premium
Company Announcements
Daiichi Sankyo Posts Strong Q1 Revenue Growth but Lower Net Profit, Lifts Dividend Outlook
25d ago
Daiichi Sankyo Revises FY2026 Results After SG&A Accounting Error
Premium
Company Announcements
Daiichi Sankyo Revises FY2026 Results After SG&A Accounting Error
25d ago
Daiichi Sankyo Extends ESOP-Based Share Grant Plan for U.S. Staff
PremiumCompany Announcements
Daiichi Sankyo Extends ESOP-Based Share Grant Plan for U.S. Staff
25d ago
Daiichi Sankyo Company (DSKYF) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Daiichi Sankyo Company (DSKYF) Q1 Earnings Cheat Sheet
27d ago
DB-Guide Trial: AstraZeneca and Daiichi Sankyo Expand ENHERTU’s First-Line Breast Cancer Strategy
PremiumCompany Announcements
DB-Guide Trial: AstraZeneca and Daiichi Sankyo Expand ENHERTU’s First-Line Breast Cancer Strategy
1M ago
Daiichi Sankyo’s New Cancer Drug DS1025a Enters First-in-Human Testing
PremiumCompany Announcements
Daiichi Sankyo’s New Cancer Drug DS1025a Enters First-in-Human Testing
2M ago
DSKYF
Daiichi Sankyo’s Pediatric Cancer Trial Adds Quiet Momentum to Its ADC Pipeline
PremiumCompany AnnouncementsDaiichi Sankyo’s Pediatric Cancer Trial Adds Quiet Momentum to Its ADC Pipeline
2M ago
DSKYF
Daiichi Sankyo Secures ¥200 Billion Syndicated Loan with Tight Financial Covenants
Premium
Company Announcements
Daiichi Sankyo Secures ¥200 Billion Syndicated Loan with Tight Financial Covenants
2M ago
Daiichi Sankyo Corrects FY2025 Presentation Materials Without Changing Financial Results
Premium
Company Announcements
Daiichi Sankyo Corrects FY2025 Presentation Materials Without Changing Financial Results
3M ago
Daiichi Sankyo Publishes Detailed FY2025 Consolidated Financial Data
PremiumCompany Announcements
Daiichi Sankyo Publishes Detailed FY2025 Consolidated Financial Data
4M ago
Daiichi Sankyo lifts dividend as profit dips on non-recurring factors
PremiumCompany Announcements
Daiichi Sankyo lifts dividend as profit dips on non-recurring factors
4M ago
DSKYF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
DSKYF Upcoming Earnings Report: What to Expect?
4M ago
Daiichi Sankyo Advances ADC Pipeline With New Esophageal Cancer Study
PremiumCompany Announcements
Daiichi Sankyo Advances ADC Pipeline With New Esophageal Cancer Study
4M ago
DSKYF
Daiichi Sankyo Terminates Early Cancer Trial DS-9606a: What Investors Should Know
PremiumCompany AnnouncementsDaiichi Sankyo Terminates Early Cancer Trial DS-9606a: What Investors Should Know
5M ago
DSKYF
Daiichi Sankyo Backs Triple Cholesterol Therapy in New Phase 3 Heart Study
Premium
Company Announcements
Daiichi Sankyo Backs Triple Cholesterol Therapy in New Phase 3 Heart Study
5M ago
DSKYF
Daiichi Sankyo Advances Triple Cholesterol Combo Pill With Completed Bioequivalence Study
Premium
Company Announcements
Daiichi Sankyo Advances Triple Cholesterol Combo Pill With Completed Bioequivalence Study
6M ago
DSKYF

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >